Health-related quality of life and clinical characteristics of hidradenitis suppurativa in a paediatric population
https://doi.org/10.4081/dr.2024.10086
Accepted: 31 August 2024
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Hidradenitis Suppurativa (HS) is a chronic, Skin Immune-Mediated Inflammatory Disease (sIMID), with a high impact on Quality of Life (QoL). Data on clinical management, comorbidities, psychosocial burden, and psychiatric disorders in paediatric patients with HS is scarce. The aim of our study was to compare clinical characteristics and Patient-Reported Outcome Measures (PROMs) for Health-Related Quality of Life (HRQoL) in adult and paediatric patients with HS. Data were collected on 601 patients with HS, 60 of whom (10.0%) were paediatric. The psychological and HRQoL impact was generally higher in adults than in children, but it was noteworthy also in paediatric patients. Early diagnosis and interventions based on education for the patients and their families and psychological support are the key to optimal disease management and adherence. Our study underlines the need for screening for HS-associated psychiatric disorders and for using age-specific tools to evaluate HRQoL. A multidisciplinary approach involving several specialists is needed, as well as liaison with primary care specialists to improve care, and management of comorbidities and psychological issues in patients with HS.
Napolitano M, Megna M, Timoshchuk EA, et al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin CosmetInvestig Dermatol 2017;10:105-15. DOI: https://doi.org/10.2147/CCID.S111019
Liy-Wong C, Pope E, Lara-Corrales I. Hidradenitis suppurativa in the pediatric population. J Am Acad Dermatol 2015;73:S36-41.
Bettoli V, Ricci M, Zauli S, et al. Hidradenitis suppurativa-acne inversa: a relevant dermatosis in paediatric patients. Br J Dermatol 2015;173:1328-30. DOI: https://doi.org/10.1111/bjd.13951
Choi E, Ting OX, Chandran NS. Hidradenitis suppurativa in pediatric patients. J Am Acad Dermatol 2022;86:140-7. DOI: https://doi.org/10.1016/j.jaad.2020.08.045
Liy-Wong C, Pope E, Lara-Corrales I. Hidradenitis suppurativa in the pediatric population. J Am Acad Dermatol 2015;73:S36-41. DOI: https://doi.org/10.1016/j.jaad.2015.07.051
Palmer RA, Keefe M. Early-onset hidradenitis suppurativa. Clin Exp Dermatol 2001;26:501-3. DOI: https://doi.org/10.1046/j.1365-2230.2001.00876.x
Lopes S, Gomes N, Trindade E, et al. Hidradenitis suppurativa in a prepubertal girl. Acta Dermatovenerol Alp Pannonica Adriat 2019;28:139-41. DOI: https://doi.org/10.15570/actaapa.2019.34
Deckers IE, Van der Zee HH, Boer J, et al. Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement. J Am Acad Dermatol 2015;72:485-8. DOI: https://doi.org/10.1016/j.jaad.2014.11.017
Kromann CB, Ibler KS, Kristiansen VB, et al. The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol 2014;94:553-7. DOI: https://doi.org/10.2340/00015555-1800
Saunte DM, Boer J, Stratigos A, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol 2015;173:1546-9. DOI: https://doi.org/10.1111/bjd.14038
Sampogna F, Fania L, Mastroeni S, et al. Age-specific physical and mental health status in Italian patients with hidradenitis suppurativa: a comparison with the general population. Arch Dermatol Res 2021;313:41-7. DOI: https://doi.org/10.1007/s00403-020-02063-4
Shavit E, Dreiher J, Freud T, et al. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J EurAcad Dermatol Venereol 2015;29:371-6. DOI: https://doi.org/10.1111/jdv.12567
Wright S, Strunk A, Garg A. Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa. J Am Acad Dermatol 2022;86:55-60. DOI: https://doi.org/10.1016/j.jaad.2021.06.843
Tiri H, Jokelainen J, Timonen M, et al. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. J Am Acad Dermatol 2018;79:514-9. DOI: https://doi.org/10.1016/j.jaad.2018.02.067
McAndrew R, Lopes FCPS, Sebastian K, et al. Quality of life in hidradenitis suppurativa: A cross-sectional study of a pediatric population. J Am Acad Dermatol 2021;84:829-30.
Seivright J, Collier E, Grogan T, et al. Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: a retrospective analysis. Pediatr Dermatol 2021;38:1132-6. DOI: https://doi.org/10.1111/pde.14765
Bettoli V, Cazzaniga S, Scuderi V, et al. Hidradenitis Suppurativa Epidemiology: From the First Italian Registry in 2009 to the Most Recent Epidemiology Updates - Italian Registry Hidradenitis Suppurativa Project 2. J EurAcad Dermatol Venereol 2019;33:4-6. DOI: https://doi.org/10.1111/jdv.15826
Kim Y, Lee J, Kim HS, et al. Review of Scoring Systems for Hidradenitis Suppurativa. Ann Dermatol 2024;36:9-17. DOI: https://doi.org/10.5021/ad.23.090
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) a Simple Practical Measure for Routine Clinical Use. Clin Exp Dermatol 1994;19:210-6. DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): Initial Validation and Practical Use. Br J Dermatol 2010;132:942-9. DOI: https://doi.org/10.1111/j.1365-2133.1995.tb16953.x
Goldberg DP. The Detection of Psychiatric Illness by Questionnaire. Oxford University Press; London, UK; 1972.
Brazier JE, Harper R, Jones NM, et al. Validating the SF-36health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160-4. DOI: https://doi.org/10.1136/bmj.305.6846.160
Sampogna F, Campana I, Fania L, et al. Pain as defining feature of health status and prominent therapeutic target in patients with hidradenitis suppurativa. J Clin Med 2021;10:3648. DOI: https://doi.org/10.3390/jcm10163648
McAndrew R, Lopes FCPS, Sebastian K, et al. Quality of life in hidradenitis suppurativa: A cross-sectional study of a pediatric population. J Am Acad Dermatol 2021;84:829-30. DOI: https://doi.org/10.1016/j.jaad.2020.09.072
Smidt AC, Lai JS, Cella D, et al. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease. Arch Dermatol 2010;146:865-9. DOI: https://doi.org/10.1001/archdermatol.2010.161
Rundle CW, Rietcheck H, Militello M, et al. Pediatric hidradenitis suppurativa with concomitant bipolar disorder: an underrepresented population. Dermatology 2021;237:769-70. DOI: https://doi.org/10.1159/000511894
Andersen PL, Kromann C, Fonvig CE., et al. Hidradenitis suppurativa in a cohort of overweight and obese children and adolescents. Int J Dermatol 2020;59:47-51. DOI: https://doi.org/10.1111/ijd.14639
Reichert B, Faith EF, Katya Harfmann K. Weight counseling in pediatric hidradenitis suppurativa patients. Pediatr Dermatol 2020;37:480-3. DOI: https://doi.org/10.1111/pde.14131
Van Geel MJ, Maatkamp M, Oostveen AM, et al. Comparison of the dermatology life quality index and the children’s dermatology life quality index in assessment of quality of life in patients with psoriasis aged 16-17 years. Br J Dermatol 2016;174:152-7. DOI: https://doi.org/10.1111/bjd.14163
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
